TherapeuticsMD, Inc. (TXMD)
Nasdaq: TXMD · CIK 0000025743 · United States
Every official TherapeuticsMD, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open TXMD filings
TherapeuticsMD, Inc. documents
- TherapeuticsMD, Inc. 10-K 2026TXMD 10-K 2026: annual report for fiscal 2026
- TherapeuticsMD, Inc. 10-K 2025TXMD 10-K 2025: annual report for fiscal 2025
- TherapeuticsMD, Inc. 10-K 2024TXMD 10-K 2024: annual report for fiscal 2024
- TherapeuticsMD, Inc. 10-K 2023TXMD 10-K 2023: annual report for fiscal 2023
- TherapeuticsMD, Inc. 10-K 2022TXMD 10-K 2022: annual report for fiscal 2022
- TherapeuticsMD, Inc. 10-Q 2026TXMD 10-Q 2026: quarterly report for fiscal 2026
- TherapeuticsMD, Inc. 10-Q 2025TXMD 10-Q 2025: quarterly report for fiscal 2025
- TherapeuticsMD, Inc. 10-Q 2024TXMD 10-Q 2024: quarterly report for fiscal 2024
- TherapeuticsMD, Inc. 10-Q 2023TXMD 10-Q 2023: quarterly report for fiscal 2023
- TherapeuticsMD, Inc. 10-Q 2022TXMD 10-Q 2022: quarterly report for fiscal 2022
- TherapeuticsMD, Inc. 8-K 2026TXMD 8-K 2026: current report for fiscal 2026
- TherapeuticsMD, Inc. 8-K 2025TXMD 8-K 2025: current report for fiscal 2025
- TherapeuticsMD, Inc. 8-K 2024TXMD 8-K 2024: current report for fiscal 2024
- TherapeuticsMD, Inc. 8-K 2023TXMD 8-K 2023: current report for fiscal 2023
- TherapeuticsMD, Inc. 8-K 2022TXMD 8-K 2022: current report for fiscal 2022
- TherapeuticsMD, Inc. DEF 14A 2026TXMD DEF 14A 2026: proxy statement for fiscal 2026
- TherapeuticsMD, Inc. DEF 14A 2025TXMD DEF 14A 2025: proxy statement for fiscal 2025
- TherapeuticsMD, Inc. DEF 14A 2024TXMD DEF 14A 2024: proxy statement for fiscal 2024
- TherapeuticsMD, Inc. DEF 14A 2023TXMD DEF 14A 2023: proxy statement for fiscal 2023
- TherapeuticsMD, Inc. DEF 14A 2022TXMD DEF 14A 2022: proxy statement for fiscal 2022
- TherapeuticsMD, Inc. Form 4 2026TXMD Form 4 2026: insider trading filing for fiscal 2026
- TherapeuticsMD, Inc. Form 4 2025TXMD Form 4 2025: insider trading filing for fiscal 2025
- TherapeuticsMD, Inc. Form 4 2024TXMD Form 4 2024: insider trading filing for fiscal 2024
- TherapeuticsMD, Inc. Form 4 2023TXMD Form 4 2023: insider trading filing for fiscal 2023
- TherapeuticsMD, Inc. Form 4 2022TXMD Form 4 2022: insider trading filing for fiscal 2022
- TherapeuticsMD, Inc. S-1 2026TXMD S-1 2026: registration statement for fiscal 2026
- TherapeuticsMD, Inc. S-1 2025TXMD S-1 2025: registration statement for fiscal 2025
- TherapeuticsMD, Inc. S-1 2024TXMD S-1 2024: registration statement for fiscal 2024
- TherapeuticsMD, Inc. S-1 2023TXMD S-1 2023: registration statement for fiscal 2023
- TherapeuticsMD, Inc. S-1 2022TXMD S-1 2022: registration statement for fiscal 2022
- TherapeuticsMD, Inc. 13F 2026TXMD 13F 2026: institutional holdings for fiscal 2026
- TherapeuticsMD, Inc. 13F 2025TXMD 13F 2025: institutional holdings for fiscal 2025
- TherapeuticsMD, Inc. 13F 2024TXMD 13F 2024: institutional holdings for fiscal 2024
- TherapeuticsMD, Inc. 13F 2023TXMD 13F 2023: institutional holdings for fiscal 2023
- TherapeuticsMD, Inc. 13F 2022TXMD 13F 2022: institutional holdings for fiscal 2022
More companies